NEWSpublisher 2007 :: AngloChinese Investments
SEARCH NEWS
date from:
date to:
company:
search for string:
NEWS SECTIONS
COMPANY GROUPS
TOP NEWS
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS » Industry news back to previous page show list
»11/04/2007 [Industry news]
ATMI LifeSciences and Austar have created a joint venture, ATMI Austar LifeSciences, Ltd

ATMI LifeSciences and Austar have created a joint venture, ATMI Austar LifeSciences, Ltd., to produce and market high-end, ultra-clean sterile materials packaging for the pharmaceutical industry in the Asia-Pacific region. "This joint venture provides ATMI LifeSciences access to the active pharmaceutical ingredient and biopharmaceutical markets in Asia as well production capacity in addition to our Belgian operation," said Mario Philips, Managing Director of ATMI LifeSciences.

 

ATMI LifeSciences and Austar have created a joint venture, ATMI Austar LifeSciences, Ltd., to produce and market high-end, ultra-clean sterile materials packaging for the pharmaceutical industry in the Asia-Pacific region.
"This joint venture provides ATMI LifeSciences access to the active pharmaceutical ingredient and biopharmaceutical markets in Asia as well production capacity in addition to our Belgian operation," said Mario Philips, Managing Director of ATMI LifeSciences. "Austar offers broad expertise and an existing ISO Class V GMP-certified cleanroom-based infrastructure that we can begin to leverage immediately. Together, under the ATMI Austar LifeSciences banner, we are working to create a new standard for advanced materials packaging for pharmaceutical manufacturing throughout the region."
"More flexibility at lower cost means the pharmaceutical manufacturers are converting to the film-based, single-use packaging products that ATMI Austar LifeSciences will be able to provide locally," said Mars Ho, Chief Executive Officer of Austar. "The pharmaceutical market in Asia is expanding rapidly as more multinational firms look to extend their manufacturing capabilities into this vital region. Local supply and support is an important competitive differentiator."
Under the joint venture agreement, ATMI Austar LifeSciences will be producing ATMI LifeSciences products, including CleanSteam(r) products, with local blow-film extrusion and packaging converting lines using a copy-exact strategy.


AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.